A Novel Rat Model for Human Meibomian Gland Dysfunction and Ocular Rosacea

Linxin Zhu1, Daniela Rodrigues-Braz1, Emmanuelle Gélizé1

  • 1Centre de Recherche des Cordeliers, Université de Paris, Sorbonne Université, Inserm, UMRS1138, Team Physiopathology of Ocular Diseases: Therapeutic Innovations, Paris, France.

Abstract

Insights

Researchers developed a rat model for ocular rosacea (OR) and Meibomian gland dysfunction (MGD). This model mimics human disease, offering insights into pathophysiology and potential new treatments for this chronic eye condition.

Area of Science:

  • Ophthalmology
  • Dermatology
  • Translational Medicine

Background:

  • Ocular rosacea (OR) is a chronic, vision-threatening ocular surface disease linked to Meibomian gland dysfunction (MGD).
  • OR and MGD are often underdiagnosed and lack effective cures due to poorly understood pathogenesis.
  • Reliable animal models are crucial for advancing research in OR and MGD.

Purpose of the Study:

  • To develop and validate a novel rat model of Meibomian gland dysfunction (MGD) and ocular rosacea (OR).
  • To compare the induced MGD and OR in rats with human pathology for translational relevance.

Main Methods:

  • Rat upper eyelids were exposed to controlled UVB radiation.
  • Clinical signs, Meibomian gland morphology/function, transcriptomics, and lipidomics were analyzed.
  • Comparisons were made with human ocular rosacea and Meibomian gland dysfunction samples.

Main Results:

  • UVB exposure induced acute eyelid and Meibomian gland damage, including oxidative stress and inflammation.
  • Persistent Meibomian gland duct hyperkeratinization and stem cell depletion led to MGD and corneal defects.
  • The rat model exhibited fibrosis and gene/lipid expression patterns similar to human OR and MGD.

Conclusions:

  • The developed rat model is a valuable tool for studying MGD pathophysiology in OR.
  • This model aids in evaluating novel therapeutic strategies for ocular rosacea.
  • Shared molecular pathways and lipid profiles offer potential biomarkers for diagnosis and treatment targets.